Heather A Cubie

Summary

Country: UK

Publications

  1. pmc Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
    K Cuschieri
    Scottish HPV Reference Laboratory, Specialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh, UK
    Br J Cancer 102:930-2. 2010
  2. ncbi request reprint The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies
    Heather A Cubie
    Specialist Virology Centre, Royal Infirmary of Edinburgh, 51 Little France Cres, Edinburgh EH16 4SA, UK
    J Clin Virol 33:287-92. 2005
  3. ncbi request reprint The role of human papillomavirus testing in cervical screening
    Kate S Cuschieri
    Specialist Virology Centre, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK
    J Clin Virol 32:S34-42. 2005
  4. ncbi request reprint Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring
    Kate S Cuschieri
    Specialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh, Scotland
    J Med Virol 73:65-70. 2004
  5. ncbi request reprint Development of an automated extraction procedure for detection of human papillomavirus DNA in liquid based cytology samples
    Kate S Cuschieri
    Regional Clinical Virology Laboratory, Lothian University Hospitals NHS Trust, The Royal Infirmary of Edinburgh, Little France, 51 Little France Crescent, Edinburgh EH16 4SA, UK
    J Virol Methods 107:107-13. 2003
  6. ncbi request reprint The HPV test in cervical screening: a brave new world?
    M S Desai
    Cytopathology 16:3-6. 2005
  7. pmc Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:6565-9. 2005
  8. ncbi request reprint Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18
    Jose C Prado
    Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Virology 340:95-104. 2005
  9. pmc Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:13630-40. 2005
  10. ncbi request reprint Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?
    Tolga Turan
    Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA 92697, USA
    Virology 349:175-83. 2006

Collaborators

Detail Information

Publications10

  1. pmc Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
    K Cuschieri
    Scottish HPV Reference Laboratory, Specialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh, UK
    Br J Cancer 102:930-2. 2010
    ..This study evaluated human papillomavirus (HPV) type prevalence in 370 Scottish invasive cervical cancers (ICCs) using HPV genotyping and HPV mRNA detection...
  2. ncbi request reprint The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies
    Heather A Cubie
    Specialist Virology Centre, Royal Infirmary of Edinburgh, 51 Little France Cres, Edinburgh EH16 4SA, UK
    J Clin Virol 33:287-92. 2005
    ..As HPV testing represents a new technology, a quality assurance (QA) programme is necessary to confirm the accuracy of results...
  3. ncbi request reprint The role of human papillomavirus testing in cervical screening
    Kate S Cuschieri
    Specialist Virology Centre, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK
    J Clin Virol 32:S34-42. 2005
    ..Due to the diversity of existing cytology-based screening programmes, full cost-effectiveness analyses of HPV testing should be performed and assessed within local contexts...
  4. ncbi request reprint Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring
    Kate S Cuschieri
    Specialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh, Scotland
    J Med Virol 73:65-70. 2004
    ....
  5. ncbi request reprint Development of an automated extraction procedure for detection of human papillomavirus DNA in liquid based cytology samples
    Kate S Cuschieri
    Regional Clinical Virology Laboratory, Lothian University Hospitals NHS Trust, The Royal Infirmary of Edinburgh, Little France, 51 Little France Crescent, Edinburgh EH16 4SA, UK
    J Virol Methods 107:107-13. 2003
    ..In short, 5 ml of liquid based cytology specimen is recommended for nucleic acid extraction, to allow optimal detection of HPV types in clinical samples while retaining maximum efficiency of the robotic extraction procedure...
  6. ncbi request reprint The HPV test in cervical screening: a brave new world?
    M S Desai
    Cytopathology 16:3-6. 2005
  7. pmc Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:6565-9. 2005
    ..We conclude that subtypes of HPV types are natural and old taxa, equivalent to types, which either diverged more recently than types or evolved more slowly...
  8. ncbi request reprint Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18
    Jose C Prado
    Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Virology 340:95-104. 2005
    ....
  9. pmc Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:13630-40. 2005
    ..Some had one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic diversity between the variants of each HPV type...
  10. ncbi request reprint Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?
    Tolga Turan
    Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA 92697, USA
    Virology 349:175-83. 2006
    ....